Neurology Advisor5d
Meningococcal Vaccination Recommended Before Switch to Ravulizumab in NMOSD
For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.
Monthly Prescribing Reference12d
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Yahoo Finance13d
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25. The vaccine targets five major ...
Healio5d
FDA cancels meeting to pick flu vaccine components for next season
The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...
Arabian Business8d
Saudi Arabia announces mandatory vaccine for Umrah 2025
Saudi Arabia’s Ministry of Health has stressed the necessity of receiving the meningitis vaccine for those intending to ...
clinicaladvisor.com11d
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug ...